Ritanserin in Treatment of Cocaine Dependence - 1
NCT00000187 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80
Last updated 2015-05-28
Summary
The purpose of this study is to assess ritanserin as a pharmacotherapy for cocaine dependence.
Conditions
- Cocaine-Related Disorders
Interventions
- DRUG
-
Ritanserin
Sponsors & Collaborators
-
National Institute on Drug Abuse (NIDA)
collaborator NIH - lead OTHER
Principal Investigators
-
James Cornish, M.D. · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 28 Years
- Max Age
- 47 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1992-07-31
- Primary Completion
- 1994-06-30
Countries
- United States
Study Locations
More Related Trials
-
Methylphenidate Treatment for Cocaine Abuse and ADHD - 1
NCT00136734 ·Status: COMPLETED ·Phase: PHASE1
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
Risperidone for Treatment of Cocaine Dependence in Outpatients - 12
NCT00000347 ·Status: COMPLETED ·Phase: PHASE2
-
Early Phase II Trials for Cocaine Medication Development - 1
NCT00000317 ·Status: COMPLETED ·Phase: PHASE2
-
Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1
NCT00000309 ·Status: TERMINATED ·Phase: PHASE2
-
Medications for Stopping Cocaine Dependence and Preventing Relapse
NCT00218023 ·Status: COMPLETED ·Phase: PHASE2
-
Piracetam for Treatment of Cocaine Addiction - 3
NCT00000198 ·Status: COMPLETED ·Phase: PHASE1
-
Rebalancing the Serotonergic System in Cocaine Dependence
NCT03266939 ·Status: WITHDRAWN ·Phase: PHASE1
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1
NCT00094315 ·Status: UNKNOWN ·Phase: PHASE1
-
Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2
NCT00000310 ·Status: TERMINATED ·Phase: PHASE2
-
Improving Learning-based Treatment of Cocaine Dependence With Medication
NCT01526538 ·Status: COMPLETED ·Phase: PHASE2
-
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
NCT00000324 ·Status: COMPLETED ·Phase: PHASE2
-
Alterations in Serotonergic Functions in Cocaine Addicts - 1
NCT00000312 ·Status: COMPLETED ·Phase: PHASE1
-
Disulfiram for Cocaine Abuse
NCT00395850 ·Status: COMPLETED ·Phase: PHASE2
-
Propranolol for Treatment of Cocaine Addiction - 2
NCT00000197 ·Status: COMPLETED ·Phase: PHASE2
-
Piracetam for Treatment of Cocaine Addiction, Phase II - 4
NCT00000199 ·Status: WITHDRAWN ·Phase: PHASE1
-
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
NCT00218348 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients.
NCT02255357 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
New Approaches to Cocaine Abuse Medications (A) - 6
NCT00000271 ·Status: COMPLETED ·Phase: PHASE2
-
Vigabatrin for Treatment of Cocaine Dependence
NCT00611130 ·Status: COMPLETED ·Phase: PHASE2
-
Risperidone for the Treatment of Cocaine Dependence - 7
NCT00000342 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1
NCT00040066 ·Status: UNKNOWN ·Phase: PHASE1
-
Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression
NCT00249444 ·Status: COMPLETED ·Phase: PHASE2
-
Vigabatrin for the Treatment of Cocaine Dependency
NCT01281202 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
NCT00000189 ·Status: COMPLETED ·Phase: PHASE2